BIGG

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

Rossing, Peter; Caramori, Luiza M; Chan, Juliana C. N; Earley, Amy; de Boer, Ian H.

Kidney int; 102 (5), 2022

The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...

Insuficiencia Renal Crónica/tratamiento farmacológico, Diabetes Mellitus Tipo 2/prevención & control, Automanejo, Control Glucémico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Antagonistas de Receptores de Angiotensina/uso terapéutico, Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico

Texto completo

SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline

Clinical question What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular ...